Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,300 | 100 | -197,000 | 152,000 | 105,700 |
| Depreciation Amortization | 76,900 | 38,900 | 139,200 | 119,900 | 80,100 |
| Income taxes - deferred | -21,800 | -13,000 | -17,900 | 11,900 | 13,000 |
| Accounts receivable | 49,200 | 52,800 | 79,500 | -48,700 | -70,600 |
| Accounts payable and accrued liabilities | -400 | -33,600 | -49,900 | 39,300 | 41,300 |
| Other Working Capital | 202,600 | 41,900 | -103,700 | -126,700 | -126,000 |
| Other Operating Activity | -51,800 | -24,700 | 380,700 | 22,800 | 38,500 |
| Operating Cash Flow | $230,400 | $62,400 | $230,900 | $170,500 | $82,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -116,300 | -63,500 | -180,000 | -116,300 | -69,900 |
| Other Investing Activity | 7,000 | 5,700 | -13,400 | -4,700 | -4,700 |
| Investing Cash Flow | $-109,300 | $-57,800 | $-193,400 | $-121,000 | $-74,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -17,800 | -13,700 | -3,000 | -2,900 | -7,600 |
| Debt Issued | 108,000 | 70,000 | 282,000 | 241,000 | 128,100 |
| Debt Repayment | -200,300 | -71,000 | -278,700 | -222,600 | -147,100 |
| Common Stock Issued | 1,500 | 1,500 | 11,200 | 10,800 | 8,500 |
| Common Stock Repurchased | N/A | N/A | -46,400 | -46,400 | -19,500 |
| Dividend Paid | -6,500 | -5,900 | -24,600 | -17,900 | -11,900 |
| Other Financing Activity | 0 | 0 | 5,300 | 3,300 | 2,500 |
| Financing Cash Flow | $-115,100 | $-19,100 | $-54,200 | $-34,700 | $-47,000 |
| Exchange Rate Effect | 900 | -2,800 | -4,800 | -1,400 | 2,700 |
| Beginning Cash Position | 55,300 | 55,300 | 76,800 | 76,800 | 76,800 |
| End Cash Position | 62,200 | 38,000 | 55,300 | 90,200 | 39,900 |
| Net Cash Flow | $6,900 | $-17,300 | $-21,500 | $13,400 | $-36,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 230,400 | 62,400 | 230,900 | 170,500 | 82,000 |
| Capital Expenditure | -116,300 | -63,500 | -180,000 | -116,300 | -69,900 |
| Free Cash Flow | 114,100 | -1,100 | 50,900 | 54,200 | 12,100 |